PD-1/PD-L1 expression in extra-medullary lesions of multiple myeloma

Leuk Res. 2016 Oct:49:98-101. doi: 10.1016/j.leukres.2016.09.008. Epub 2016 Sep 5.

Abstract

Multiple myeloma patients may develop extraosseous involvement in the course of the disease making prognosis very poor and new drugs clearly needed. The PD-1/PD-L1 axis has emerged as a master immune checkpoint in antitumor responses and recent studies investigated the role of PD-L1 in multiple myeloma cells; no data however are still available about PD-L1 expression in extramedullary localizations. We demonstrate PD-L1 expression in 4/12 cases of extraosseous myeloma suggesting that these lesions represent a specialized microenvironment. We found presence of PD-1+ infiltrating lymphocytes in all observed cases supporting the relevance of PD-1/PD-L1 checkpoint in extramedullary myeloma. We also investigated the correlation in PD1/PD-L1 staining between marrow staining and EMP lesions.

Keywords: Extramedullary myeloma; Immunohistochemistry; PD-1; PD-L1.

MeSH terms

  • Adult
  • Aged
  • B7-H1 Antigen / analysis*
  • Bone Marrow Examination
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Leukemic Infiltration / pathology
  • Middle Aged
  • Multiple Myeloma / pathology*
  • Programmed Cell Death 1 Receptor / analysis*

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor